SOURCE: Bederra Corp.

August 07, 2009 10:00 ET

Bederra Corporation Shareholder and Business Update

HOUSTON, TX--(Marketwire - August 7, 2009) - Bederra Corporation (PINKSHEETS: BEDA), a Houston, Texas based, diversified medical services provider announced that it will soon publish its six month financial results (1st and 2nd quarter) and upgrade the company's current "Pink Sheets Limited Information" categorization to a "Pink Sheets Current Issuer" listing. The issuance of the first six months of financial statements was expected by the end of July, but was delayed slightly by management's desire to have the financial statements consolidated and reviewed by an accounting group so that the disclosure is up to date and ready to be audited at year end. The company will be posting the financial statements on and announcing their availability and summarized results via a press release.

Also to the end of upgrading its disclosure category on Pink Sheets, the company recently reported that it is in the process of changing transfer agents; this lengthy process should be completed within the next two weeks. The official date of the change will also be announced.

Additionally, management announced that the company is in the process of revising its corporate structure and creating a 5 person Board of Directors that will be compliant with Sarbanes /Oxley rules, should the company seek an up listing to another exchange. The company also intends to appoint an advisory board comprised of physicians and medical industry professionals to advise the company on expansion strategies.

Finally, the previously announced potential acquisition of Neogenex Medical Technologies is progressing and is undergoing customary due diligence evaluation. Neogenex Medical Technologies, Inc. is a Houston, Texas based Technology, Development and Marketing company that focuses on Pain Therapies for Arthritis, Soft tissue and Joint applications. It has rights to patents and technology to produce and market a low level laser device cleared by the FDA to treat arthritis pain and carpal tunnel syndrome. The company currently markets these FDA approved devices to medical professionals, Fitness Clubs and Corporate Wellness Facilities. More than 3,500 medical professionals, therapists and trainers are currently using these devices as treatment options.

About Bederra Corp.

Bederra Corporation, through its wholly owned subsidiaries Lumar Imaging, Inc., Reliant Medical Group and Diagnos, Inc., provides multiple modality diagnostic medical imaging services to the greater Houston area and the world famous Texas Medical Center. The Company's business strategy is to continue to expand its current operations and seek out additional acquisitions that will complement its core offerings.

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products and services in development, including any planned acquisitions, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements might not occur. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact Information